{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"69"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"10"},{"groupId":"OG004","value":"40"}],"units":"Participants"}],"description":"Kalbfleisch and Prentice estimate of the percentage of experiencing TRM 100 days after the date of transplant. (Events=TRM, competing events=relapse)","groups":[{"description":"Patients who met eligibility criteria and received transplant.","id":"OG000","title":"All Transplant Participants"},{"description":"Patients who met eligibility criteria, received transplant, and received 1x10\\^5 cells/kg","id":"OG001","title":"Dose 1"},{"description":"Patients who met eligibility criteria, received transplant, and received 1x10\\^6 cells/kg","id":"OG002","title":"Dose 2"},{"description":"Patients who met eligibility criteria, received transplant, and received 1x10\\^7 cells/kg","id":"OG003","title":"Dose 3"},{"description":"Patients who met eligibility criteria, received transplant, and were assigned the MED dose of 1x10\\^7 cells/kg","id":"OG004","title":"Phase 2"}],"paramType":"NUMBER","populationDescription":"Patients who met eligibility criteria and received transplant.","reportingStatus":"POSTED","timeFrame":"100 days after receiving transplant","title":"The Cumulative Incidence of Transplant Related Mortality","type":"SECONDARY","unitOfMeasure":"percentage of participants"}